Nrf2: A key regulator in chemoradiotherapy resistance of osteosarcoma
Osteosarcoma (OS), frequently observed in children and adolescents, is one of the most common primary malignant tumors of the bone known to be associated with a high capacity for invasion and metastasis. The incidence of osteosarcoma in children and adolescents is growing annually, although improvem...
Saved in:
| Main Authors: | Xianglin Peng, Jing Feng, Han Yang, Ping Xia, Feifei Pu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2025-07-01
|
| Series: | Genes and Diseases |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352304224001326 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sulfasalazine induces ferroptosis in osteosarcomas by regulating Nrf2/SLC7A11/GPX4 signaling axis
by: Qingqing Qin, et al.
Published: (2025-08-01) -
Shikonin suppresses proliferation of osteosarcoma cells by inducing ferroptosis through promoting Nrf2 ubiquitination and inhibiting the xCT/GPX4 regulatory axis
by: Rui Huang, et al.
Published: (2024-12-01) -
NRF3 suppresses squamous carcinogenesis, involving the unfolded protein response regulator HSPA5
by: Selina Gurri, et al.
Published: (2023-10-01) -
Nrf2/cyclooxygenase 2 signaling in Cr(VI)-induced carcinogenesis
by: Lei Zhao, et al.
Published: (2025-02-01) -
Ubiquitination in osteosarcoma: unveiling the impact on cell biology and therapeutic strategies
by: Jianlin Shen, et al.
Published: (2024-10-01)